News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

OXiGENE (OXGN) to Present at 12th Annual Biotechnology Industry Organization (BIO) Investor Forum Conference on October 8, 2013



10/1/2013 9:25:52 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, Calif., Sept. 30, 2013 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, announced that Peter Langecker, M.D., Ph.D., President and Chief Executive Officer, will provide a corporate overview at the 12th Annual BIO Investor Forum conference on October 8, 2013 at 4:00 PT at the Palace Hotel, San Francisco, California.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES